Waving not drowning: tackling NHS reform
September 18, 2006Sales and Marketing NHS, healthcare, marketing, strategy
New NHS initiatives, restructuring plans and government health policies seem to be announced and introduced on a never-ending basis, with …
NHS preparing to cut A&E and maternity units
September 14, 2006The new chief executive of the NHS, David Nicholson, is drawing up plans to close a series of key hospital …
Lipitor patients sue Pfizer
September 14, 2006Sales and Marketing patients
A series of personal injury lawsuits filed in the US have taken aim at Pfizer's marketing practices for its blockbuster …
PCTs to retain clinical leadership role
September 13, 2006Professional executive committees, the bodies once seen as the engine room for reform of the NHS, are to be retained …
DHL deal ‘catastrophic’ for UK medical devices industry
September 13, 2006DHL's new contract to manage procurement across the NHS threatens the future of UK medical devices firms, according to manufacturers. …
Dolan forced out over Plavix affair
September 13, 2006Sales and Marketing ethics
Peter Dolan, the chief executive of Bristol-Myers Squibb has been forced to resign after the company's legal advisor called for …
New PCTs to tighten general practice prescribing controls
September 12, 2006Moves to rein in the prescribing freedom of GPs and give prescribing advisors more power are gaining ground in the …
A fresh look at advertising
September 11, 2006Medical Communications advertising
Mary Poppins knew only too well that a spoonful of sugar makes the medicine go down. But in these sugar-free …
NICE takes aim at ineffective treatments
September 7, 2006NICE is to review use of ineffective treatments by the NHS with the aim of saving millions of pounds – …
Public affairs agency Advocate launched
September 7, 2006Medical Communications
A former Labour Party press officer has launched the first independent public affairs agency dedicated exclusively to healthcare.Camden-based Advocate's managing …
NicOx to develop enhanced statin product
September 6, 2006Research and Development
NicOx is to develop a new statin treatment using its special in-house technology which, according to the company, could make …
Collaboration to develop new Parkinson’s Disease dyskinesia treatment
September 6, 2006Research and Development
Santhera Pharmaceuticals is collaborating with Finnish biotech company Juvantia Pharma to develop a treatment for dyskinesia, the distressing involuntary movements …
Think-tank calls for new cancer strategy
September 6, 2006Health think-tank the King's Fund has called for a fundamental re-examination in the way NHS cancer services are provided in …
NHS ‘sell off’ angers unions
September 5, 2006The government has signed a deal with logistics company DHL to take over the purchase of essential items to the …
Cannabis-derived MS treatment filed in Europe
September 5, 2006Sales and Marketing GW Pharmaceuticals, Sativex
Sativex, the cannabis-derived product developed by GW Pharmaceuticals could be finally set for approval after a delay of around two …
Generic Plavix challenge hits BMS and Sanofi forecasts
September 5, 2006Sales and Marketing
A US district court has granted an injunction to stop sales of the generic version of blood-thinner Plavix, the world's …
AstraZeneca and charity spin-off collaborate on colorectal cancer research
September 4, 2006Research and Development
AstraZeneca is to work with a spin-off company set up by Cancer Research UK to research and develop new treatments …
One in four older patients missing out on medicines
September 4, 2006Sales and Marketing patients
More than a quarter of older patients in the UK are missing out on medicines, either because they simply fail …
NICE called on to lead the fight against obesity
September 1, 2006Following grim warnings that more than 12 million adults and one million children in England will be obese in less …
How to make your move
September 1, 2006Business Services career, planning, recruitment
According to a recent survey, four out of every 10 employees are thinking about changing their job in the next …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
